Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    17667984 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Irbesartan Versus Placebo in Combination With Ramipril for Treatment of Albuminuria
Condition: Albuminuria
Interventions: Drug: Ramipril + Irbesartan;   Drug: Ramipril + Placebo

Indicates status has not been verified in more than two years